UPMC Pathologists and Researchers Develop Technology That Predicts Prostate Cancer Relapse

New lab test market could open up if research findings lead to a useful clinical laboratory test that predicts prostate cancer recurrence Over the past decade, clinical laboratory tests that can predict the occurrence or recurrence of breast cancer have opened up a profitable market for the companies that developed these technologies. Now, new research may become the basis of a useful medical laboratory test that could be predictive of prostate cancer relapse. Of course, pathologists know that...

IBM Watson Picks Advisory Board—but No Pathologist

Clinical laboratory managers and pathologists have an opportunity to expand the presence of laboratory medicine IBM (NYSE: IBM) recently issued a press release announcing its new Watson Healthcare Advisory Board (WHAB). The board is comprised of healthcare leaders with a broad range of research, medical and business expertise. Unfortunately, that expertise does not include pathology or specialists in laboratory medicine. “Watson represents a technology breakthrough that can help...

Pathologist Becich ID’s Three Most Important Developments in Pathology Informatics

Dark Daily recently caught up with Michael J. Becich, M.D., Ph.D. from the University of Pittsburgh School of Medicine. He is the Course Director of the upcoming APIII conference on anatomic pathology informatics and imaging support for translational medicine and an international expert on the digitization of anatomic pathology. We queried Dr. Becich about his views on the three most important new developments in pathology informatics. Because he is on cutting edge of new technologies and...
;